PharmaBiotechnology
Lyka Labs Ltd
LYKALABS · NSE · INE933A01014Wednesday, 8 Jul 2026Vol: 13.3K traded · 62.2% delivered
Market Cap₹219 Cr
P/E104.2
P/B2.2
EPS₹0.6
Div Yield0.0%
ROE0.0%
ROCE0.0%
Standalone Financials
Parent-company view for users who want to strip subsidiary effects from the base story.
| Period |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Depreciation |
| Interest |
| Profit Before Tax |
| Tax |
| Net Profit |
| EPS (₹) |
| Dividend Payout % |
Standalone history locked
Register freeRegister free to see 13 more years.